1. Tang, Zengwei, Yang, Yuan, Chen, Wen, Liang, Tingbo. 2023. Epigenetic deregulation of MLF1 drives intrahepatic cholangiocarcinoma progression through EGFR/AKT and Wnt/β-catenin signaling. In Hepatology communications, 7, . doi:10.1097/HC9.0000000000000204. https://pubmed.ncbi.nlm.nih.gov/37486965/
2. Lv, Jian, Chen, Qin, Wang, Junmei, Tong, Jingjing, Wang, Zhihua. . Downregulation of MLF1 safeguards cardiomyocytes against senescence-associated chromatin opening. In Nucleic acids research, 53, . doi:10.1093/nar/gkae1176. https://pubmed.ncbi.nlm.nih.gov/39657728/
3. Zhang, Lei, Ji, Guoqing, Shao, Yuzhang, Sun, Huiming, Shao, Chen. 2015. MLF1 interacting protein: a potential gene therapy target for human prostate cancer? In Medical oncology (Northwood, London, England), 32, 454. doi:10.1007/s12032-014-0454-1. https://pubmed.ncbi.nlm.nih.gov/25572810/
4. Li, Xiaojun, Min, Shengping, Wang, Hongtao, Chen, Yuqing, Wang, Xiaojing. 2018. MLF1 protein is a potential therapy target for lung adenocarcinoma. In International journal of clinical and experimental pathology, 11, 3533-3541. doi:. https://pubmed.ncbi.nlm.nih.gov/31949731/
5. Darracq, Anaïs, Pak, Helen, Bourgoin, Vincent, Affar, El Bachir, Milot, Eric. 2019. NPM and NPM-MLF1 interact with chromatin remodeling complexes and influence their recruitment to specific genes. In PLoS genetics, 15, e1008463. doi:10.1371/journal.pgen.1008463. https://pubmed.ncbi.nlm.nih.gov/31675375/
智鼠故事 
